Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jun;22(2):112-114.
doi: 10.3121/cmr.2024.1899.

Extreme Reactive Thrombocytosis Caused by Obstructive Nephrolithiasis and Pyelonephritis

Jeffrey Zhong  1 , Clifford D Packer  2
Affiliations
Case Reports

Extreme Reactive Thrombocytosis Caused by Obstructive Nephrolithiasis and Pyelonephritis

Jeffrey Zhong et al. Clin Med Res. 2024 Jun.

Abstract

Platelet counts in reactive thrombocytosis rarely exceed 1000 × 109/L. We present the case of a male patient, aged 80 years, with quiescent rheumatoid arthritis who was found to have a platelet count of 1011 × 109/L on routine laboratory testing. The patient was initially asymptomatic but developed leukocytosis to 23.1 × 109/L on hospital day 2. Diagnostic work-up revealed obstructive nephrolithiasis and pyelonephritis, and the thrombocytosis and leukocytosis gradually resolved with empiric antibiotic treatment and ureteral stent placement. Tests for myeloproliferative disorders, including JAK-2V617F mutation, BCR-ABL for chronic myeloid leukemia and acute lymphocytic leukemia, and myeloproliferative neoplasms (MPL/CALR), were negative. Physicians should be aware that in rare cases reactive thrombocytosis can exceed 1000 × 109/L, and that markedly elevated platelet counts in the setting of urinary tract infections may be an early sign of obstructive uropathy.

Keywords: Geriatrics; Hematology; Obstructive uropathy; Reactive thrombocytosis; Urinary tract infection.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Clinical course in a man, aged 80 years, with reactive thrombocytosis caused by obstructive nephropathy and pyelonephritis.
See this image and copyright information in PMC

References

    1. Araneda M, Krishnan V, Hall K, Kalbfleisch J, Krishnaswamy G, Krishnan K.. Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins. South Med J. 2001;94(4):417-420. - PubMed
    1. Senchenkova EY, Ansari J, Becker F, et al. . Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation [published correction appears in Circulation. 2019 Jul 23;140(4):e172. doi: 10.1161/CIR.0000000000000713]. Circulation. 2019;140(4):319-335. doi:10.1161/CIRCULATIONAHA.118.039345 - DOI - PMC - PubMed
    1. Schattner A, Kadi J, Dubin I.. Reactive thrombocytosis in acute infectious diseases: Prevalence, characteristics and timing. Eur J Intern Med. 2019;63:42-45. doi:10.1016/j.ejim.2019.02.010. - DOI - PubMed
    1. Bergmann K, Bergmann OJ.. An unusual case of extreme thrombocytosis caused by iron deficiency. BMJ Case Rep. 2020;13(1):e231833. doi:10.1136/bcr-2019-231833. - DOI - PMC - PubMed
    1. Muhammed ZAE, Alfatih M, Babiker ASH, et al. . Extreme thrombocytosis with severe anemia and infection in a Sudanese patient: A case report. Ann Med Surg (Lond). 2022;84:104927. doi:10.1016/j.amsu.2022.104927. - DOI - PMC - PubMed

Publication types

Substances